Catalyst Capital Advisors LLC Guardant Health, Inc. Transaction History

Catalyst Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$59.49 - $82.78 $12,552 - $17,466	-211 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$62.59 - $110.3 $2,816 - $4,963	45 Added 27.11%	211 $13,000
Q2 2019 Aug 08, 2019	BUY	$63.94 - $91.11 $4,795 - $6,833	75 Added 82.42%	166 $14,000
Q1 2019 May 08, 2019	SELL	$34.3 - $97.98 $514 - $1,469	-15 Reduced 14.15%	91 $7,000
Q4 2018 Feb 07, 2019	BUY	$29.2 - $46.1 $3,095 - $4,886	106 New	106 $4,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.